135 related articles for article (PubMed ID: 8773587)
1. IL-8 release from human neutrophils by the respiratory syncytial virus is independent of viral replication.
König B; Krusat T; Streckert HJ; König W
J Leukoc Biol; 1996 Aug; 60(2):253-60. PubMed ID: 8773587
[TBL] [Abstract][Full Text] [Related]
2. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes.
Arnold R; Werner F; Humbert B; Werchau H; König W
Immunology; 1994 Jun; 82(2):184-91. PubMed ID: 7927487
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus G-protein modulates cytokine release from human peripheral blood mononuclear cells.
König B; Streckert HJ; Krusat T; König W
J Leukoc Biol; 1996 Mar; 59(3):403-6. PubMed ID: 8604019
[TBL] [Abstract][Full Text] [Related]
4. Oxidant tone regulates IL-8 production in epithelium infected with respiratory syncytial virus.
Mastronarde JG; Monick MM; Hunninghake GW
Am J Respir Cell Mol Biol; 1995 Aug; 13(2):237-44. PubMed ID: 7626291
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells.
Fiedler MA; Wernke-Dollries K; Stark JM
Am J Physiol; 1995 Dec; 269(6 Pt 1):L865-72. PubMed ID: 8572249
[TBL] [Abstract][Full Text] [Related]
6. Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.
Arnold R; König B; Galatti H; Werchau H; König W
Immunology; 1995 Jul; 85(3):364-72. PubMed ID: 7558123
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
Becker Y
Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
[TBL] [Abstract][Full Text] [Related]
8. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
Johnson TR; Parker RA; Johnson JE; Graham BS
J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
Miller AL; Bowlin TL; Lukacs NW
J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides.
Jairath S; Vargas PB; Hamlin HA; Field AK; Kilkuskie RE
Antiviral Res; 1997 Feb; 33(3):201-13. PubMed ID: 9037376
[TBL] [Abstract][Full Text] [Related]
11. Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific.
Levitz R; Wattier R; Phillips P; Solomon A; Lawler J; Lazar I; Weibel C; Kahn JS
Virol J; 2012 Sep; 9():190. PubMed ID: 22962966
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.
Karron RA; Buonagurio DA; Georgiu AF; Whitehead SS; Adamus JE; Clements-Mann ML; Harris DO; Randolph VB; Udem SA; Murphy BR; Sidhu MS
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13961-6. PubMed ID: 9391135
[TBL] [Abstract][Full Text] [Related]
14. Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines.
Bukreyev A; Whitehead SS; Prussin C; Murphy BR; Collins PL
J Virol; 2000 Aug; 74(15):7151-7. PubMed ID: 10888656
[TBL] [Abstract][Full Text] [Related]
15. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.
Becker S; Quay J; Soukup J
J Immunol; 1991 Dec; 147(12):4307-12. PubMed ID: 1753101
[TBL] [Abstract][Full Text] [Related]
16. The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.
Teng MN; Collins PL
J Virol; 2002 Jun; 76(12):6164-71. PubMed ID: 12021350
[TBL] [Abstract][Full Text] [Related]
17. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease.
Cortjens B; de Boer OJ; de Jong R; Antonis AF; Sabogal Piñeros YS; Lutter R; van Woensel JB; Bem RA
J Pathol; 2016 Feb; 238(3):401-11. PubMed ID: 26468056
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression.
Arnold R; König W
J Immunol; 2005 Jun; 174(11):7359-67. PubMed ID: 15905583
[TBL] [Abstract][Full Text] [Related]
20. Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.
Russell RF; McDonald JU; Ivanova M; Zhong Z; Bukreyev A; Tregoning JS
J Virol; 2015 Sep; 89(17):8974-81. PubMed ID: 26085154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
